Launched by the Movember Foundation in 2014, the GAP3 Prostate Cancer Active Surveillance (GAP3) initiative aims to help improve how men living with low-risk prostate cancer are managed and reduce the burden of them being over-treated. This is the third of Movember's Global Action Plan (GAP) projects, which help to connect unprecedented numbers of international doctors and researchers to collaborate on a global scale.